COMPANY

We are a specialty pharmaceutical company engaged in the development of a new generation of therapeutic compounds through the application of our proprietary metal coordination chemistry to existing medications. We create these novel compounds by covalently binding metals to known pharmaceutical agents to create new, patentable products that are typically safer, more stable, and more effective than their predecessors. 

Metal coordination improves a pharmacologically active agent’s performance by increasing its effective bioavailability, reducing its variability of absorption and hastening or sustaining its release in the body.  Further, metal coordination can improve the stability of biologic drugs and, through incorporation of other agents, permit targeted and synergistic delivery of drugs to specific cells or tissues.  

We believe that our novel metal coordination chemistry can be profitably applied to wide range of drugs.  We have identified over 400 drug candidates for potential complexation and have begun work on several of new compounds.  In addition to using metal coordination to modulate absorption of biologically active agents, we are pursuing new chemistry that exploits potential synergies between the biologically active agents themselves.  We believe that this novel chemistry could significantly improve the efficacy of drugs that are used in a variety of prevalent disease states.